Clinical Significance: Olanzapine is an atypical antipsychotic drug used in the treatment of bipolar disorder and schizophrenia.
Tested in urine only
Drug Class
Antipsychotics
Metabolite(s)
Desmethylolanzapine
Aliases
Zyprexa
Methodology
Liquid Chromatography Mass Spectrometry
Urine Recommended Volume
30mL
Oral Fluid Minimum Volume
N/A
Specimen Stability
15 days
Urine Reportable Range
40*
Oral Fluid Reportable Range
N/A
Urine Immunoassay Cutoff (ng/mL)
N/A
Urine Window of Detection
1-3 days
Oral Fluid Window of Detection
N/A
Rejection Criteria
Quantity Not Sufficient
Urine Transient Contanier
Urine Clinical Drug Test Transport Cup
Oral Fluid Transient Contanier
N/A